4D Molecular Therapeutics Inc.
4DMT Highlights Robust and Durable Clinical Activity for 4D 150 and[...]
LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030,[...]
12/24/2021 | News release | Distributed by Public on 12/24/2021 06:22
Please select the service you want to use:
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact